Pyrogen Testing Market Going to Rake US$1,527.8 Mn by the end of 2024

The global pyrogen testing market is exceptionally consolidated as a few players hold a dominant share in the overall market. The leading players, Thermofisher, Lonza Group, Charles River Laboratories International, Inc., and Merck KGaA, held a lion’s share of 51% in the global market in 2015. Transparency Market Research observes that these companies are expected to retain their leadership as they are focused on development products that are do not require rabbit pyrogen testing along with strategic mergers and acquisitions.

The players are determined to retain their presence in the global competition and contribute significantly to soaring revenues through the forecast period. According to the research report by Transparency Market Research, the opportunity in the global pyrogen testing market is expected to be worth US$1,527.8 mn by the end of 2024 as compared to US$570.0 mn in 2015. During the forecast period of 2016 and 2024, the global market is expected to surge at a CAGR of 11.9%.

North America to Show High Adoption of Pyrogen Testing between 2016 and 2024

Of all the geographical segments in the global market, North America is anticipated to show an incredible CAGR of 11.6% during the forecast period. This growth is being fueled by the majority of pharmaceutical investing in the region due to favorable support from the governments. Amongst the types of tests, the limulus amoebocyte lysate (LAL) test is expected to lead the market as it is poised to surge at a CAGR of 12.6% during the forecast period.

Browse Full Research Report: https://www.transparencymarketresearch.com/pyrogen-testing-market.html

Prevalence of Chronic Conditions Urges Pharmaceutical Companies to Develop New Drugs

The high prevalence of diseases and conditions that require innovative drugs for treatment has triggered a huge demand for pyrogen testing in recent years. The growing demand for biological drugs is also projected to boost the market. The robust pipelines and approvals of new drugs are also expected to help the global market grow in the coming few years. The emergence of biotechnology and pharmaceutical companies and their rising investments in research and development of innovative therapeutics have also played a crucial part in the rise of the global pyrogen testing market in the recent years. “The growing number of clinical researches to treat the hazardous evolution of infectious diseases and diseases pertaining to unhealthy lifestyle changes has pressurized the pharmaceutical industry to develop enhanced drugs,” states the lead author of this research report. As the epidemics and outbreaks continue, they are likely to provide an impetus to the global market during the forecast period.

The various types of tests available in the global market are recombinant factor C assay (rFC), monocyte activation test (MAT), limulus amoebocyte lysate (LAL) test, and rabbit pyrogen test (RPT). Of these, the limulus amoebocyte lysate (LAL) test is being extensively adopted by several drug manufacturing and development companies. Analysts anticipate that LAL will retain its dominance in the global market as it offers the best quality control. Thus, this testing method is being used for detecting the minute quantity of bacterial toxins or pyrogen in medical devices, pharmaceuticals, and other areas.

Ban on Animal Testing Shadows Growth of Global Market

The ardent efforts to ban the usage of animals for testing is the biggest restraint in the global pyrogen testing market. For instance, growing hue and cry over usage of rabbits for pyrogen testing has raised questions and thus is expected to hamper the testing possibilities in the coming years. The global market is also being hampered due to the demanding nature of monocyte activation test (MAT). This testing method requires fresh human blood, which poses as a logistics challenge and adds to the already expensive nature of testing.

Advertisements

Cervical Dysplasia Market Going to Rake US$ 640.2 Mn by the end of 2024

The global market for cervical dysplasia features a highly consolidated competitive landscape, with the top three companies accounting for over 76% of the overall market in 2015, observes a recent report by Transparency Market Research. These top vendors, namely Qiagen AG, Hologic Inc., and F. Hoffmann-La Roche Ltd, have strengthened their hold on the market owing to strategies such as collaboration with leading pharmaceutical and biotechnology companies and successful and focused R&D activities.

Low product penetration clubbed with vast untapped growth prospects across developing economies is a key incremental opportunity for market players. Thus, companies could benefit from increased focus on strong promotional campaigns in developing economies where nearly 90% of cervical cancer deaths occur on an annual basis.

Transparency Market Research estimates that the global cervical dysplasia market will exhibit a healthy CAGR of 7.0% over the period between 2016 and 2024. If the prediction holds true, the market, which valued at US$349.0 mn in 2015, is expected to rise to US$ 640.2 mn by 2024.

Browse Full Research Report: https://www.transparencymarketresearch.com/cervical-dysplasia-market.html

Demand across Developed Regions to Remain Pivotal to Generating Sustainable Profits

In terms of diagnosis, the global cervical dysplasia market is dominated by the diagnostic tests segment, which accounted for over 85% of the overall market in 2015. The rising awareness regarding cervical dysplasia and the vast rise in cervical cancer screening programs in developed countries are the key factors attributed to the high share of the segment in the global market.

Geographically, the market earns a large share of its overall revenue from developed regions such as North America and Europe, which collectively accounted for over 80% of the overall market in 2015. The trend is expected to remain strong over the forecast period as well. Nevertheless, emerging economies across regions such as Asia Pacific and Latin America also present highly promising growth opportunities.

Government-funded Healthcare Screening Programs to Present Vast Growth Opportunities

Funds invested by governments towards several healthcare screening programs in a number of developed countries with the aim of preventing several high-incidence cancers are key to the overall development of the global cervical dysplasia market. Over the forecast period as well, the impact of this factor on the overall development of the market is expected to remain significantly high. The rising number of people to undergo cervical screening tests such as Pap smear, HPV, and colposcopy owing to such government initiatives is an excellent growth area for market players.

Rising Aversion to Pap Smear Tests to Have Negative Impact on Market Development

Pap smear tests currently hold a significant share in the overall market for cervical dysplasia diagnostic tests. The trend is primarily attributed to the immense success of widespread Pap smear screening programs undertaken in developed countries. In the past decade, however, the number of Pap screening tests has drastically come down, chiefly owing to less than optimal Pap test characteristics, with about 25% to 40% false-negative rate despite the implementation of extensive quality assurance standards.

This potential for missing out on critical cervical cancer symptoms with Pap screening alone has led to the development of enhanced cytology-based screening technologies and increased research activities aimed at understanding the etiologic role of human papillomavirus in causing cervical cancer. The resultant advancements in HPV screening technologies have made HPV testing one of the primary cervical cancer screening tools in the past years, allowing this segment to largely surpass the business of Pap smear screening tests. Although this factor presents an incremental growth opportunity for players in the HPV testing market, the aversion to the lucrative Pap smear screening test segment is expected to hamper the global cervical dysplasia market in the near future.

Advanced Wound Care Management Market Will Rake US$11,161.6 Mn by the end of 2024

Becton Dickinson and Company Group plc., Baxter International Inc., Terumo Medical Corporation, and Medtronic are the top four players that dominate over half the prefilled syringes market. Transparency Market Research has noted that the global prefilled syringes market is highly dynamic and competitive and while the nature of the market is consolidated in developed regions owing to the presence of large players, it remains fragmented in most of the emerging markets with many small regional players.

The global sales of prefilled syringes amounted to US$3.5 bn in 2015 and is projected to reach US$7.9 bn, expanding at a CAGR of 9.3% over the period of 2016 to 2024. In terms of prefilled syringes consumption, the market is expected to expand at a CAGR of 9.0% during the forecast period.

Ambulatory Surgical Centers to Show Promising Growth over Forecast Period

By application, the vaccines segment dominated the global prefilled syringes market, accounting for a collective share of 34.3% in 2015. The segment is also projected to exhibit a strong growth rate from 2016 to 2024. In terms of percentage share contribution, the polymer-based prefilled syringes segment is expected to continue its lead in the global market through 2024. It will also register the highest growth in the coming years. By distribution channel, the hospitals segment is projected to account for the major share by the end of the forecast period. On the other hand, ambulatory surgical centers are likely to register a high growth rate by 2024.

North America dominates the global market, while Asia Pacific is expected to witness strong growth. The U.S. is the largest market for prefilled syringes, accounting for around 35.5% share of the global market

Browse Full Research Report: https://www.transparencymarketresearch.com/prefilled-syringes-market.html

Improving Safety Standards Driving Innovation among Product Manufacturers

The incidence of needle stick injuries has been a cause for concern over the years. According to the World Health Organization, almost two million healthcare professionals suffer from infectious diseases resulting from needle stick injuries each year.

“Various needle safety devices – such as passive needle guarding caps with a polymer shield and a retractable needle system – as well as advanced technologies – such as advanced barrel technology and multi-chamber syringes – are being developed to cope with this problem,” the author of the study finds. Therefore, improving safety standards and technological advancements have been primarily driving the global prefilled syringes market.

High Costs Associated with Prefilled Syringes Inhibiting widespread Adoption

There are several factors that pose a severe challenge to the growth of the global prefilled syringes market, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs. “In order to maintain specified temperatures and conditions throughout the shelf life of a drug, drug manufacturing companies require several complex machineries that need to be maintained regularly,” the TMR analyst states. This is a costly affair and as a result, restricts companies from manufacturing prefilled syringes.

Other factors inhibiting the market include product recalls due to breakages and leachables, the potential risk of interaction between prefilled syringes and drugs, and the availability of alternative drug delivery methods.

Prefilled Syringes Market Will Rake US$7.9 Bn by the end of 2024

Becton Dickinson and Company Group plc., Baxter International Inc., Terumo Medical Corporation, and Medtronic are the top four players that dominate over half the prefilled syringes market. Transparency Market Research has noted that the global prefilled syringes market is highly dynamic and competitive and while the nature of the market is consolidated in developed regions owing to the presence of large players, it remains fragmented in most of the emerging markets with many small regional players.

The global sales of prefilled syringes amounted to US$3.5 bn in 2015 and is projected to reach US$7.9 bn, expanding at a CAGR of 9.3% over the period of 2016 to 2024. In terms of prefilled syringes consumption, the market is expected to expand at a CAGR of 9.0% during the forecast period.

Ambulatory Surgical Centers to Show Promising Growth over Forecast Period

By application, the vaccines segment dominated the global prefilled syringes market, accounting for a collective share of 34.3% in 2015. The segment is also projected to exhibit a strong growth rate from 2016 to 2024. In terms of percentage share contribution, the polymer-based prefilled syringes segment is expected to continue its lead in the global market through 2024. It will also register the highest growth in the coming years. By distribution channel, the hospitals segment is projected to account for the major share by the end of the forecast period. On the other hand, ambulatory surgical centers are likely to register a high growth rate by 2024.

North America dominates the global market, while Asia Pacific is expected to witness strong growth. The U.S. is the largest market for prefilled syringes, accounting for around 35.5% share of the global market

Browse Full Research Report: https://www.transparencymarketresearch.com/prefilled-syringes-market.html

Improving Safety Standards Driving Innovation among Product Manufacturers

The incidence of needle stick injuries has been a cause for concern over the years. According to the World Health Organization, almost two million healthcare professionals suffer from infectious diseases resulting from needle stick injuries each year.

“Various needle safety devices – such as passive needle guarding caps with a polymer shield and a retractable needle system – as well as advanced technologies – such as advanced barrel technology and multi-chamber syringes – are being developed to cope with this problem,” the author of the study finds. Therefore, improving safety standards and technological advancements have been primarily driving the global prefilled syringes market.

High Costs Associated with Prefilled Syringes Inhibiting widespread Adoption

There are several factors that pose a severe challenge to the growth of the global prefilled syringes market, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs. “In order to maintain specified temperatures and conditions throughout the shelf life of a drug, drug manufacturing companies require several complex machineries that need to be maintained regularly,” the TMR analyst states. This is a costly affair and as a result, restricts companies from manufacturing prefilled syringes.

Other factors inhibiting the market include product recalls due to breakages and leachables, the potential risk of interaction between prefilled syringes and drugs, and the availability of alternative drug delivery methods.

Medical Aesthetic Devices Market Will Rake US$15.1 Bn by the end of 2024

The global market for medical aesthetic devices is characterized by a highly consolidated competitive landscape, wherein the top two vendors, Mentor Worldwide LLC and Allergan Plc., collectively held a nearly 60% of the market in 2015, observes a recent report by Transparency Market Research. Mentor Worldwide LLC, the market leader with a 32% share in the global market, stayed ahead of the competition with the help of strategic collaborations and a strong emphasis on aesthetic products such as breast implants and body contouring.

In September 2016, the company announced its plans for a new collaboration with Galderma, a medical solutions firm with strong operations in skin health. Under the collaboration, the companies plan to partner with Canadian surgeons to improve patient experience across innovative aesthetic procedures and solutions, broadening consumers’ access to and awareness of aesthetic treatment options.

Browse Full Research Report: https://www.transparencymarketresearch.com/medical-aesthetics.html

Transparency Market Research estimates that the global medical aesthetic devices market will rise from a valuation of US$6.5 bn in 2015 to US$15.1 bn in 2024. This reflects a 9.0% CAGR from 2016 through 2024. In terms of product types, the segment of laser and energy devices presently leads. The segment held a nearly 30% share in the global market in 2015 and is expected to remain one of the most promising product segments over the forecast period as well. From a geographic perspective, the market earns a significant share of its revenues from sales across developed regions such as North America and Europe. North America dominated in 2015, accounting for a 43% of the global market.

Increased Usage of Lasers for Medical Aesthetic Procedures to Stimulate Market Growth

In the past few years, the global consumer has become more open to aesthetic procedures owing to a vast reduction in cultural prohibitions and social taboos. The resultant rise in surgical procedures for enhancing personal appearance is the key driver of the global medical aesthetic devices market.

Other key trends positively influencing the overall development of the market include the increased adoption of laser-based devices, heightened demand for minimally invasive and non-invasive equipment, and the high demand for augmentation and reconstructive surgeries. The global adoption of laser-based devices has increased owing to the widening utility of laser devices.

Cost-effectiveness and versatility of laser devices are also the key factors increasing adoption and usage of laser procedures in the aesthetics market.

Increased adoption of minimally invasive surgeries, owing to the fewer post-surgery complications and side effects, and shorter recovery spans, have driven innovations and technological developments, bringing about a huge change in the quality and effectiveness of surgeries. As a result, the number of minimally invasive procedures in dermatological applications has significantly increased lately. The American Society of Plastic Surgeons estimated that the number of minimally invasive aesthetic procedures performed in the U.S. increased to 15.9 mn 2015, a rise of 2% over 2014.

Competitively Priced Equipment and Services from Domestic Vendors to Limit Market Growth

The global medical aesthetic devices market is characterized by intense competition wherein local manufacturers and service providers offer devices/services at affordable costs. The resultant need to reduce costs of equipment to stay ahead of competition can severely hamper the overall profitability of international vendors, especially across cost-sensitive emerging economies.

Continuous technological developments in the aesthetic devices market with respect to product design and efficiency require manufacturers to provide up-to-date solutions to the customers. Such upgrades could be highly cost-intensive and lead to erosion of investment and not many service providers may be open to adopting them on a regular basis. The scenario is expected to have a negative impact on the overall development of the market in the long run.

Contact Lens Market Going to Rake US$18.70 Bn by the end of 2024

The global contact lens market witnesses a highly competitive and consolidated scenario, states Transparency Market Research (TMR) in a research report. The crème of all the companies present in the market are Bausch and Lomb, Alcona Inc., The Cooper Companies, and Johnson & Johnson. In 2015, these companies collectively held a share of approximately 68% in the global contact lens market. The leading vendor in the market in the same year with 31% of the overall share was Johnson & Johnson and is expected to maintain the lead over the years ahead. With the dominance of a handful of gigantic companies, the market is expected to witness innovation in the coming years as these companies will struggle to have a competitive advantage over each other. In order to boost their revenues and grasp a strong consumer base, the market players are integrating communication, monitoring, and electronics with their merchandises. With new products extensions and growing applications, the competition in the market is expected to further intensify in the years ahead. The other prominent companies are STAAR Surgical, Menicon Group, Carl Zeiss AG, Essilor International S.A., and Novartis International AG, among many others.

According to a TMR analyst, “The global market for contact lens is expected to register a CAGR of 7.6% between 2016 and 2024. In 2015, the market was worth US$9.74 bn and is projected to rise to a valuation of US$18.70 bn by the end of 2024.”

Browse Full Research Report: https://www.transparencymarketresearch.com/contact-lens-market.html

Cast Molding Surfaces as Most Preferred Manufacturing Technology

The core technologies that are used for contact lens manufacturing are lathe cutting, cast molding, and spin casting. Amongst all these the most sought after technology in 2015 was cast molding with an overall share of 80% in the global contact lens market and it is expected that it will maintain the dominant position in the coming years. The growth of the market can be attributed to the computer controlled and automated manufacturing of the contact lenses with the aid of the technology of cast molding. This process assures the manufacturer of high quality and accuracy in the end product. In addition, injection molding further enables bulk manufacturing for extensively prominent disposable lens types, thus making cast molding the most preferred method for cost reduction. However, cast molding will continue its reign in the market, it might lose its popularity to the technology of lathe cutting.

Region-wise, the global market for contact lens has been segmented into North America, the Middle East and Africa, Latin America, Asia Pacific, and Europe. At present, North America leads the market with almost 30% of the overall share in the global market owing to the number of senior and middle aged ophthalmological patients and a significant rise in ophthalmic issues in the region. However, Asia Pacific is expected to give a tough competition to North America with the most promising and lucrative opportunities present in the market for the players in the near future.

Popularity of Lenses as a Fashion Accessory to Propel Demand Globally

The rise in the number of cases of weekend eyesight and refractory errors among the young population has increased the adoption of contact lenses globally. Youngsters are incessantly preferring contact lenses for aesthetics, convenience, and comfort and their easy availability with variety of colors and disposable varieties have also triggered their use a fashion accessory among the young and middle aged population. Furthermore, regular attempts are being made by manufacturers of contact lens for educating the masses regarding their ease of use and benefits. But damage due to careless usage is expected limit its mass adoption in the coming years such as sleeping wearing lenses or poor handling during storage.

Hearing Aids Market Going to Rake US$7.01 Bn by the end of 2024

The global hearing aids market is highly consolidated with only six players holding a high share in the revenue pie. As per a new analysis by Transparency Market Research, a whopping 98% of the global hearing aids market was held by the leading six companies in 2015. Among these, Sonava accounted for the 25% of the market in the same year. Due to the high expenditure incurred on the initial production set-up and research and development, new entrants find it difficult to cut through the competition. Despite the absence of direct competition, the increasing interest in prosthetic implants could adversely impact the demand for hearing aids.

Nevertheless, companies manufacturing hearing aids and amplification products are poised to witness incredible growth opportunities in the near future. “Although the market has been growing at a modest pace since the last few years, the increasing geriatric population will fuel demand for hearing loss support in the near future,” says an analyst at TMR. “Furthermore, with hearing impairment emerging as one of the most prevalent chronic conditions worldwide, the sale of hearing aids is expected to increase in the forthcoming years,” he added.

Browse Full Research Report: https://www.transparencymarketresearch.com/hearing-aid-market.html

High Price of Hearing Aids to Limit Adoption across Low-income Countries

Developing and underdeveloped countries have been witnessing a higher prevalence of hearing loss among their citizens. Governments across these countries are thus compelled to adopt various awareness initiatives aimed at curbing the incidence of hearing loss. Such initiatives are expected to positively influence sale of hearing aid products across developing and underdeveloped economies.

On the flip side, the high price of hearing aids and cost incurred on maintaining them limit their purchase among low-income people. Furthermore, the device requires periodic replacements, which might not be feasible for a sizeable population across underdeveloped countries, thus restricting the market’s trajectory. The lack of timely diagnosis of hearing impairment is another factor limiting growth of the hearing aids market across developing and underdeveloped nations.

Nevertheless, these countries will continue exhibiting attractive opportunities for manufacturers of hearing aids. With government of these countries proactively involved to up the health status of the community, the favorable policies they draft are expected to give significant impetus to the hearing aid sales.

Presence of Unmet Medical Needs to Propel Hearing Aids Sales in Asia Pacific

Regionally, the prospects for hearing aid products are seen to be the most lucrative in Europe. The region, TMR says, held approximately 39% of the global market in 2015. The robust demand for hearing aids in this region is mainly attributed to the high pool of aged population, especially in Western Europe, and the increasing willingness among consumers to pay for advanced medical devices.

In the same year, North America followed Europe in the global hearing aids market. Asia Pacific is poised to exhibit the fastest CAGR during the forecast period. The prevalence of a high degree of unmet medical needs is expected to boost the Asia Pacific market for hearing aids at a CAGR of 5.2% between 2015 and 2024.

High Prevalence of Hearing Impairment among Adults Fuels Demand for Hearing Aids

By end user, the hearing aids market has been bifurcated into adult and pediatric in the TMR analysis. Of these, since the incidence of hearing impairment is exceptionally high among adults, the segment held approximately 95% of the market in 2015. However, experts forecast the incidence of hearing loss to rise among children at a considerable rate in the near future, thus boosting the pediatric hearing aids segment at a high CAGR.

Transparency Market Research projects the global hearing aids market to exhibit a CAGR of 4.5% between 2016 and 2024. The market is expected to be worth US$7.01 bn by the end of 2024, rising from US$4.7 bn in 2015.

Metabolomics Market Going to Rake US$2.49 Bn by the end of 2024

A large pool of players with a robust presence points towards the high degree of competition in the global metabolomics.market Thermo Fisher, Biocrates Life Sciences, Agilent Technologies, Shimadzu, Human Metabolome Technologies, Waters, Metabolon, LECO, Bruker, and Bio-Rad Laboratories are some of the key companies leading this market, finds a new research report by Transparency Market Research (TMR).

Hitherto, these companies have relied upon innovation and product advancements for the growth of their business. Over the coming years, a shift in their focus towards strategic alliances can be observed, states the market study.

According to TMR’s estimations, the global market metabolomics will expand at a healthy CAGR of 17.10% during the period from 2016 to 2024 and reach a value of US$2.49 bn by the end of the forecast period. Drug assessment, nutrigenomics, biomarker discovery, and clinical toxicology have emerged as the key application areas for metabolomics across the world, states the report.

Browse Full Research Report: https://www.transparencymarketresearch.com/metabolomics-market.html

Demand for HPLC technique to remain Strong

The report considers separation and detection as the prime techniques utilized in metabolomics. Gas chromatography, high performance liquid chromatography (HPLC), capillary electrophoresis, and ultra-performance liquid chromatography (UPLC) have surfaces as the key separation techniques, among which, HPLC technique enjoys the most prominent demand across the world. Researchers project this trend to continue over the next few years.

In terms of geography, the market reports its presence across Latin America, the Middle East and Africa, North America, Europe, and Asia Pacific. Among these, North America and Europe has been leading the global market and are expected to remain doing so in the years to come, notes the research study.

Surge in Demand for Personalized Medicines Propels Market

“The substantial increase in the demand for personalized medicines, especially in North America and Europe, is the main factor behind the growth of the global metabolomics market. Apart from this, the surge in government initiatives and funding in research and the rising need for toxicology technologies and enhanced research and development activities across a number of pharmaceutical and biotechnology sectors are also propelling this market remarkably across the world.

On the other hand, the decreasing uptake rate of advanced technologies and data processing and analysis by conventional workers and the lack of skilled professionals may restrict this market from growing steadily over the forecast period. However, the effects of these restraints will be nullified with the upswing in the opportunities presented by biomarker discovery services and the untapped markets. The technological enhancements and the increasing partnerships between key players and various research institutes are also projected to boost the market in the near future, states the report.

Dental Laboratories Market Will Rake US$ 20,234.1 Mn by the end of 2024

Transparency Market Research has published a new market report titled, “Dental Laboratories Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023.” According to the report, the global dental laboratories market was valued at US$ 12,991.6 Mn in 2014 and is projected to expand at a CAGR of 4.9% from 2015 to 2023 to reach US$ 20,234.1 Mn in 2023.

Dental laboratories are an amalgamation of art, science, and technology required for designing and manufacturing of products as a replacement of natural teeth. The scope of the research encompasses development of products such as crowns, bridges, caps, veneers, and other orthodontic splints and appliances essential to protect and straighten teeth. Similar to other areas/domains of the health care industry, the dentistry segment has witnessed significant growth over the past few years. Introduction of novel technologies and innovative materials have also attributed to the evolution of the dental laboratories market.

Browse Full Research Report: https://www.transparencymarketresearch.com/dental-laboratories-market.html

Geographically, the global dental laboratories market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World. Each region has been further analyzed and estimated for major contributing countries. For instance, North America includes the U.S. and Canada. Europe has been sub-categorized into the U.K., Germany, France, Spain, Italy, and Rest of Europe. Asia Pacific includes China, Japan, and Rest of Asia Pacific. Rest of the World has been studied and segmented into Latin America and Middle East & Africa.

Europe accounted for the lion’s share of the global dental laboratories market in 2014, followed by North America. A number of community-based oral health programs are conducted across the European Union that focus on delivery of preventive treatment, increase awareness, and enhance patient education toward various procedures and artificial dental products, which over the past few years have contributed to the growth of the dental laboratory industry. However, Asia Pacific is expected to outperform the two major contributing regions during the forecast period from 2015 to 2023. Growth of the market in Asia Pacific is primarily driven by rising trend of dental tourism and increase in the number of laboratories established in the last five years. Moreover, the market is projected to expand at a substantial growth rate due to increase in export demand for dental orthodontic, periodontics, crowns, bridges, and implants from emerging markets such as India and China. Health care provision in Africa is challenged by the burden of poverty and underdevelopment, with 80% of the population falling into the lowest socioeconomic category. Lack of financial and technical resources, shortage of health personnel, and insufficient primary health care delivery make it hard for most of the population of Africa to access basic health services. Shortage of oral health personnel is a common problem in Africa, as the average dentist to population ratio is approximately 1:150000 compared to 1:2000 in most developed economic countries.

Lack of proper reimbursement and high operational cost are the major restraints of the global dental laboratory industry. To operate a dental laboratory, around 40% to 60% of what a dentist pays goes toward the expense of running a modern dental practice. Additionally, pay for rent or mortgage payments on their office space, payroll for hygienists, office managers and receptionists, health insurance, taxes, supplies, business insurance, and technology are the other expense burdens on laboratory owners. High operational cost, intense competition, and restricted geographical reach are among the primary reasons for closure of large number of dental laboratories in the past few years that is common in both developed and emerging markets.

Advent of CAD/CAM technology has significantly reduced the design and manufacturing time for dental prosthesis such as crowns and bridges. 3D imaging techniques have improved patient diagnosis and procedure planning; hence are considered to be other factors driving sustained growth and demand for dental laboratories and services offered to dentists. Rising costs and declining insurance reimbursements have created high demand for outsourced dental laboratories work. Currently, approximately 40% to 50% dental laboratories in the U.S. use off-shore laboratory services to produce components and/or complete dental laboratory services such as crowns, bridges, single porcelain fused to gold, complete dentures, partials, and frameworks.

Key players operating in this market are 3M Health Care, Danaher Corporation, Dentcare Dental Lab, Henry Schein, Inc., Institut Straumann AG, Keating Dental Arts, Modern Dental Laboratory Co., Ltd., National Dentex Corporation, Patterson Companies, Inc., Shofu, Inc., Sirona Dental Systems, and Yenadent Ltd. Sti.

Breast Pumps Market Will Rake US$4,164.6 Mn by the end of 2025

With a few larger companies holding the largest stake, the global breast pumps market exhibits an oligopolistic vendor landscape. Among the most prominent players, companies such as Philips, Medela, and Ameda Breastfeeding Solutions are currently enjoying a stronghold, finds Transparency Market Research (TMR) in a new study. Because of its medical importance, a majority of consumers prefer investing in products by prominent brands. However, there is a considerable number of local players supplying breast pumps via indigenous network of distributors. Hence, they are able to make very little contribution toward the global breast pumps market. According to TMR, Medela LLC emerged dominant in the overall market in 2016. Besides this, some of the other notable market players include Pigeon Group (Pigeon Corporation), Evenflo Feeding, Inc., Spectra Baby USA, Mayborn Group Limited, and Hygeia Health.

According to TMR, the global breast pumps market is expected to reach US$4,164.6 mn by the end of 2025, from US$1,971.8 mn in 2016. Considering these market figures hold true, the global breast pumps market will report a positive 8.9% CAGR between 2017 and 2025. Regionally, North America held the leading market share in 2016. However, over the course of the report’s forecast period, the Asia Pacific market is likely to exhibit a higher CAGR of 9.4%.

Browse Full Research Report: https://www.transparencymarketresearch.com/breast-pumps-market.html

Rising Women Employment Positively Impacts Global Breast Pumps Market

Various factors are supporting the expansion of the global breast pumps market. For instance, the rising rate of women employment, coupled with supportive government initiatives, has proved a boon for the market. These initiatives not only helped improving the overall healthcare infrastructure but also got robust schemes for spreading awareness on track. The cumulative effect of these factors are reflected positively on the global breast pumps market, augmenting overall sales witnessed over the last few years.

Besides these, factors such as the escalating birth rate, especially among emerging nations provide lucrative opportunities to the market. The United Nations has estimated by the end of 2050 the likelihood of the global population to reach 9.7 billion. Having said that, the growth in population is also indicative of attractive prospects awaiting the market players in the near future. Alongside rising women employment worldwide, the rising disposable income of consumers will have a positive impact on the market as well. To capitalize on prevailing opportunities across emerging nations, several companies are looking to invest therein. This will definitely give the breast pumps market in emerging nations a significant impetus.

High Cost of Hospital Grade Breast Pumps Emerges as Restraining Factor

In the last few years, both public and private sector players have conducted various campaigns to spread awareness regarding the benefits of breastfeeding, in turn creating a sizeable consumer base for breast pumps in developing nations. In addition, the recent technological advancements have further helped the market gain pace. On the downside, side effects related to using breast pumps and the high price at which hospital grade breast pumps are available are restraining the market to an extent. Nonetheless, the increasing demand from emerging nations such as China will enable the market sustain its positive growth trend through the forecast period.